Advertisement
$8.75M award will help probe links with immune-related neuroinflammation
Shared medical appointments offer added resources
Possible surrogate biomarker for AD subtype, retrospective study suggests
A brain health expert looks ahead to phase 3 testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings may lead to new treatments to delay Alzheimer onset
Advertisement
Advertisement